Treatment of Generalized Itching
Start with emollients and self-care advice as first-line therapy for all patients with generalized pruritus, then escalate treatment based on the underlying cause using a systematic algorithmic approach. 1
Initial Management: First-Line Therapy
All patients should receive:
- Emollients with high lipid content to maintain skin hydration and restore the skin barrier 1, 2
- Self-care advice including avoidance of hot water, irritants, and triggers 1, 3
- For elderly patients specifically, initiate a 2-week trial of emollients plus topical steroids to exclude asteatotic eczema before proceeding further 1, 2
Topical Therapies for Generalized Pruritus of Unknown Origin (GPUO)
If emollients alone are insufficient:
- Topical doxepin (limit to 8 days, maximum 10% body surface area, 12g daily maximum) 1, 2
- Topical clobetasone butyrate or menthol preparations as alternatives 1, 2
Avoid these topical agents:
- Do not use crotamiton cream (Strength B recommendation against) 1
- Do not use topical capsaicin or calamine lotion 1
Systemic Therapies: Stepwise Escalation
Second-Line: Antihistamines
Non-sedating H1 antagonists are preferred:
- Fexofenadine 180 mg or loratadine 10 mg daily 1, 2, 4
- Mildly sedative cetirizine 10 mg may be considered 1, 3
- Consider combining H1 and H2 antagonists (e.g., fexofenadine plus cimetidine) for enhanced effect 1
Critical caveat: Sedative antihistamines (hydroxyzine) should only be used short-term or in palliative settings due to dementia risk, particularly in elderly patients 1, 2, 3
Third-Line: Neuromodulators and Psychotropics
When antihistamines fail, consider:
- SSRIs: Paroxetine or fluvoxamine 1, 2, 3
- Mirtazapine (dual serotonergic/noradrenergic action) 1, 2, 3
- Gabapentin or pregabalin (except in hepatic pruritus—see below) 1, 3
- Opioid modulators: Naltrexone or butorphanol 1, 2
- Antiemetics: Ondansetron or aprepitant 1
Cause-Specific Treatment Algorithms
Hepatic Pruritus (Cholestatic Itch)
Follow this strict hierarchy:
- First-line: Rifampicin (Strength A recommendation) 1, 2
- Second-line: Cholestyramine 1, 2
- Third-line: Sertraline 1, 2
- Fourth-line: Naltrexone or nalmefene 1, 2
- Fifth-line: Dronabinol, phenobarbitone, or topical tacrolimus 1
Critical pitfall: Do NOT use gabapentin in hepatic pruritus 1, 2
Uremic Pruritus (Chronic Kidney Disease)
Optimize dialysis parameters first:
- Normalize calcium-phosphate balance and control parathyroid hormone 2, 3
- Correct anemia 3
- BB-UVB phototherapy (Strength A recommendation—the highest quality evidence for uremic itch) 1, 2, 3
Avoid in uremic pruritus:
Drug-Induced Pruritus
Opioid-induced:
- First choice: Naltrexone if opioid cessation impossible (Strength B) 1, 2
- Alternatives: Methylnaltrexone, ondansetron, droperidol, mirtazapine, or gabapentin 1
Postoperative pruritus:
Chloroquine-induced:
Hematologic Disorders
Iron deficiency:
- Iron replacement therapy 2
Polycythemia vera:
- Cytoreductive therapy, aspirin, interferon-α, SSRIs, cimetidine, or atenolol 2
Lymphoma-Associated Pruritus
Hodgkin lymphoma:
Non-Hodgkin lymphoma:
- NB-UVB phototherapy 2
Incurable lymphoma:
- Oral corticosteroids 2
Solid Cancer-Associated Pruritus
- Paroxetine, mirtazapine, granisetron, or aprepitant 2
Neuropathic Pruritus
- Refer to neurology or appropriate specialist for definitive management 1
- Consider skin biopsy to confirm small fiber neuropathy 2
Psychogenic Pruritus (Functional Itch Disorder)
- Psychosocial and behavioral interventions: Education, relaxation techniques, cognitive restructuring, habit reversal training 1, 3
- NB-UVB phototherapy may provide benefit 1
- Referral to liaison psychiatry or psychology in selected cases 1
- Patient support groups 1, 3
Special Population: Elderly Patients
Mandatory initial approach:
- 2-week trial of emollients plus topical steroids to exclude asteatotic eczema 1, 2, 3
- High lipid content moisturizers preferred 1, 2
- Gabapentin may be beneficial if initial therapy fails 1
- Absolutely avoid sedative antihistamines (Strength C recommendation against) due to dementia risk 1, 2
When to Refer to Secondary Care
Refer if:
- Diagnostic uncertainty exists 1
- Primary care management fails to relieve symptoms 1
- Specialized phototherapy or advanced systemic therapies needed 2, 3
Alternative/Adjunctive Therapies
Consider for GPUO: